Response to Selective RET Inhibition With LOXO-292 in a Patient With Fusion-Positive Lung Cancer With Leptomeningeal Metastases.
作者信息
Guo Robin, Schreyer Mark, Chang Jason C, Rothenberg S Michael, Henry Dahlia, Cotzia Paolo, Kris Mark G, Rekhtman Natasha, Young Robert J, Hyman David M, Drilon Alexander
机构信息
Memorial Sloan Kettering Cancer Center, New York, NY.
Loxo Oncology, Stamford, CT.
出版信息
JCO Precis Oncol. 2019;3. doi: 10.1200/PO.19.00021. Epub 2019 Jun 3.
Abstract
摘要
Zotero 插件